Author: Xentech-Admin

All our news

XenTech exhibits at EACR 2022 (Seville, Jun. 20-23 2022)

We’ll be exhibiting at EACR in Seville, stop by booth #50 !

triangleDiscover
Publications

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

triangleDiscover
Publications

Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants

CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.

triangleDiscover
All our news

XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)

We’ll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)

triangleDiscover
Publications

STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021

triangleDiscover
Conferences & events

XenTech live at AACR Spotlight Series


XenTech uncovers its unique dedication into PDX field to AACR attendees on Oct. 5th 2021

 

triangleDiscover
Conferences & events

XenTech will attend BIO-EUROPE

We’ll be delighted to present you the new products and services, reach out to us !

 

triangleDiscover
Conferences & events

XenTech will attend BIOPHARM-US


We’ll be delighted to present you the new products and services, reach out to us !

 

triangleDiscover